Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.16 USD | +8.54% | +13.68% | +9.09% |
08/03 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
05/03 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.09% | 178M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- CGEN Stock
- News Compugen Ltd.
- Compugen : Expects $6 Million Milestone Payment From AstraZeneca for First Patient Dosed in Antibody-Derived Drug Study